Using related donors other than genotypically HLA-matched siblings in allogeneic hematopoietic stem cell transplantation for hematologic disease: A single institution experience in Japan

International Journal of Hematology

Volumn 76, Issue 4, 2002, Pages 354-359

  Tomonari, Akira ^a   Iseki, Tohru ^a   Ooi, Jun ^a   Takahashi, Satoshi ^a   Ishii, Koji ^a   Takahashi, Tsutomu ^a   Shindo, Motohiro ^a   Nagamura, Fumitaka ^a   Uchimaru, Kaoru ^a   Nagayama, Hitomi ^a   Shirafuji, Naoki ^a   Tojo, Arinobu ^a   Tani, Kenzaburo ^a   Asano, Shigetaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Graft versus host disease; Hematopoietic stem cell transplantation; HLA mismatch

Indexed keywords

ACUTE DISEASE; ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DONOR; GENOTYPE; HAPLOIDY; HEMATOLOGIC DISEASE; HIGH RISK POPULATION; HLA MATCHING; HUMAN; JAPAN; RISK ASSESSMENT; SIBLING; TREATMENT OUTCOME; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; BLOOD DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NUCLEAR FAMILY; PATHOLOGY; PROBABILITY;

ADOLESCENT; ADULT; CAUSE OF DEATH; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; JAPAN; MALE; MIDDLE AGED; NUCLEAR FAMILY; PROBABILITY; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 1842852787     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982696     Document Type: Article

References (17)

1. Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med. 1989;320:197-204.
2. Ash RC, Horowitz MM, Gale RP, et al. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant. 1991;7:443-452.
3. Anasetti C, Beatty PG, Storb R, et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol. 1990;29:79-91.
4. Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 1997;15:1767-1777.
5. Ottinger H, Beelen D, Sayer H, et al. Bone marrow transplantation from partially HLA-matched related donors in adults with leukaemia: the experience at the University Hospital of Essen, Germany. Br J Haematol. 1996;92:913-921.
6. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med. 1998;339:1177-1185.
7. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood. 1998;92:3515-3520.
8. Takahashi S, Okamoto SI, Shirafuji N, et al. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF) combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. Bone Marrow Transplant. 1994;13:239-245.
9. Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825-828.
10. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
11. Matsumoto K, Horibe K, Akatsuka Y, et al. Bone marrow transplantation from donors other than HLA matched siblings for hematological malignancies. Jpn J Clin Hematol. 1994;35:729-737.
12. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantation from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med. 1993;328:593-602.
13. Henslee-Downey PJ, Abhyankar SH, Parrish RS, et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood. 1997;89:3864-3872.
14. Aversa F, Tabilio A, Velardi A, et al. Treatment of high risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998;339:1186-1193.
15. Rubinstein P, Carrier C, Scaradavouy A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565-1577.
16. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815-1822.
17. Ooi J, Iseki T, Nagayama H, et al. Unrelated cord blood transplantation for adult patients with myelodysplastic syndrome-related secondary acute myeloid leukaemia. Br J Haematol. 2001;114:1-4.